Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of botulinum toxin type A for masseter hypertrophy
RBR-7tdjcn5Completed
- Sponsor
- Uningá
- Start
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in masseter hypertrophy (2 arms), sponsored by Uningá. Started Dec 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
masseter hypertrophy
Beyond the preview
Go deeper on RBR-7tdjcn5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7tdjcn5.